194 related articles for article (PubMed ID: 15069602)
21. Elevation of blood vitamin D2 levels does not impede the release of vitamin D3 from the skin.
Matsuoka LY; Wortsman J; Haddad JG; Hollis BW
Metabolism; 1992 Nov; 41(11):1257-60. PubMed ID: 1331703
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D and the Pathophysiology of Inflammatory Skin Diseases.
Umar M; Sastry KS; Al Ali F; Al-Khulaifi M; Wang E; Chouchane AI
Skin Pharmacol Physiol; 2018; 31(2):74-86. PubMed ID: 29306952
[TBL] [Abstract][Full Text] [Related]
23. Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3.
Feldmeyer L; Shojaati G; Spanaus KS; Navarini A; Theler B; Donghi D; Urosevic-Maiwald M; Glatz M; Imhof L; Barysch MJ; Dummer R; Roos M; French LE; Surber C; Hofbauer GF
J Am Acad Dermatol; 2013 Oct; 69(4):530-6. PubMed ID: 23850091
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D metabolism in psoriasis before and after phototherapy.
Guilhou JJ; Colette C; Monpoint S; Lancrenon E; Guillot B; Monnier L
Acta Derm Venereol; 1990; 70(4):351-4. PubMed ID: 1977266
[TBL] [Abstract][Full Text] [Related]
25. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3659-67. PubMed ID: 19667162
[TBL] [Abstract][Full Text] [Related]
26. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis.
Vähävihu K; Ala-Houhala M; Peric M; Karisola P; Kautiainen H; Hasan T; Snellman E; Alenius H; Schauber J; Reunala T
Br J Dermatol; 2010 Aug; 163(2):321-8. PubMed ID: 20331450
[TBL] [Abstract][Full Text] [Related]
27. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms.
van de Kerkhof PC
Br J Dermatol; 1995 May; 132(5):675-82. PubMed ID: 7772470
[TBL] [Abstract][Full Text] [Related]
28. UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis.
Osmancevic A; Landin-Wilhelmsen K; Larkö O; Mellström D; Wennberg AM; Hulthén L; Krogstad AL
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):172-8. PubMed ID: 17803595
[TBL] [Abstract][Full Text] [Related]
29. Conversion of vitamin D3 to hormonally active 1alpha,25-dihydroxyvitamin D3 in cultured keratinocytes: relevance to cell growth and differentiation.
Lehmann B; Schättiger K; Meurer M
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):322-3. PubMed ID: 20153426
[TBL] [Abstract][Full Text] [Related]
30. A novel pathway for hormonally active calcitriol.
Lehmann B; Knuschke P; Meurer M
Horm Res; 2000; 54(5-6):312-5. PubMed ID: 11595824
[TBL] [Abstract][Full Text] [Related]
31. UV-B-triggered induction of vitamin D3 metabolism differentially affects antimicrobial peptide expression in keratinocytes.
Peric M; Lehmann B; Vashina G; Dombrowski Y; Koglin S; Meurer M; Ruzicka T; Schauber J
J Allergy Clin Immunol; 2010 Mar; 125(3):746-9. PubMed ID: 20226307
[No Abstract] [Full Text] [Related]
32. The vitamin D3 1alpha-hydroxylase gene and its regulation by active vitamin D3.
Takeyama K; Kato S
Biosci Biotechnol Biochem; 2011; 75(2):208-13. PubMed ID: 21307571
[TBL] [Abstract][Full Text] [Related]
33. Rapid suppression of 7-dehydrocholesterol reductase activity in keratinocytes by vitamin D.
Zou L; Porter TD
J Steroid Biochem Mol Biol; 2015 Apr; 148():64-71. PubMed ID: 25500071
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D and the skin: an ancient friend, revisited.
Reichrath J
Exp Dermatol; 2007 Jul; 16(7):618-25. PubMed ID: 17576242
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D metabolism and chronic liver disease.
Wills MR; Savory J
Ann Clin Lab Sci; 1984; 14(3):189-97. PubMed ID: 6329069
[TBL] [Abstract][Full Text] [Related]
36. UVB-induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta7-reductase inhibitor.
Vantieghem K; Overbergh L; Carmeliet G; De Haes P; Bouillon R; Segaert S
J Cell Biochem; 2006 Sep; 99(1):229-40. PubMed ID: 16598763
[TBL] [Abstract][Full Text] [Related]
37. Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1.
Urushino N; Nakabayashi S; Arai MA; Kittaka A; Chen TC; Yamamoto K; Hayashi K; Kato S; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Drug Metab Dispos; 2007 Sep; 35(9):1482-8. PubMed ID: 17553915
[TBL] [Abstract][Full Text] [Related]
38. Vitamins as hormones.
Reichrath J; Lehmann B; Carlberg C; Varani J; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):71-84. PubMed ID: 17326003
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells.
Munetsuna E; Nakabayashi S; Kawanami R; Yasuda K; Ohta M; Arai MA; Kittaka A; Chen TC; Kamakura M; Ikushiro S; Sakaki T
J Mol Endocrinol; 2011 Oct; 47(2):209-18. PubMed ID: 21693624
[TBL] [Abstract][Full Text] [Related]
40. Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure.
Adachi Y; Uchida N; Matsuo T; Horio T
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):16-8. PubMed ID: 18201352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
